HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review.

AbstractOBJECTIVE:
Attention-deficit/hyperactivity disorder (ADHD) is observed in 30% of children and adolescents with epilepsy. Recent studies have demonstrated the safety of methylphenidate (MPH) in patients with controlled epilepsy. There are few studies of patients with uncontrolled epilepsy. The goal was to study the efficacy and safety of MPH use in children and adolescents diagnosed with ADHD and uncontrolled epilepsy.
METHODS:
We evaluated 24 patients ranging from 7 to 16 years of age who took MPH for 6 months. Inclusion criteria were at least two epileptic seizures in the previous 6 months and a diagnosis of ADHD based on DSM-IV criteria.
CONCLUSION:
Patients were classified according to ADHD subtype as follows: 41.7% inattentive type, 37.5% combined, and 20.8% hyperactive/impulsive type; 58.3% had partial epilepsy and 41.7% generalized epilepsy. There was an overall improvement in ADHD symptoms in 70.8% of patients, and there was no increase in frequency of epileptic seizures in 22 patients (91.6%).
AuthorsJulio A S Koneski, Erasmo B Casella, Fábio Agertt, Maria Gabriela Ferreira
JournalEpilepsy & behavior : E&B (Epilepsy Behav) Vol. 21 Issue 3 Pg. 228-32 (Jul 2011) ISSN: 1525-5069 [Electronic] United States
PMID21524941 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Central Nervous System Stimulants
  • Methylphenidate
Topics
  • Adolescent
  • Attention Deficit Disorder with Hyperactivity (complications, drug therapy, epidemiology)
  • Brazil (epidemiology)
  • Central Nervous System Stimulants (therapeutic use)
  • Child
  • Drug Evaluation
  • Electroencephalography
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Methylphenidate (therapeutic use)
  • Psychiatric Status Rating Scales
  • Seizures (complications, drug therapy)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: